3 Results for "

BMS986458

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "BMS986458" in MCE Product Catalog:

Cat. No.: HY-172736
CAS No.: 3005272-36-3
Synonyms: BMS-986458
Target:  

PROTACs BCL6 CD20

Research Areas:  

Cancer

Toviblideg (BMS-986458) is a highly selective, orally active cereblon-based BCL6 PROTAC degrader and antitumor agent. Toviblideg selectively degrades BCL6 by binding cereblon to the BTB domain of BCL6, thereby regulating the cell cycle, antiproliferative and interferon signaling pathways, and upregulating the expression and distribution of CD20. Toviblideg modulates the phenotype of follicular helper T cells and reduces circulating tumor DNA levels. The combination of Toviblideg with CD20xCD3 bispecific antibody also enhances the efficiency of T cell tumor infiltration and expansion. Toviblideg induces regression of BCL6-positive tumors and prolongs survival, and it is suitable for research related to B-cell non-Hodgkin lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, and relapsed/refractory lymphoma .
loading...
    loading...
Cat. No.: HY-172740
Research Areas:  

Cancer

BCL6 ligand-3 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). BCL6 ligand-3 can serve as an active control for the target protein ligand of BMS-986458 (HY-172736) .
loading...
    loading...
Cat. No.: HY-172739
CAS No.: 3005273-99-1
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 176 is an E3 ligase ligand-linker conjugate. E3 Ligase Ligand-linker Conjugate 176 can be used to synthesize BMS-986458 (HY-172736) .
loading...
    loading...